Peter Guarino
Yale University
42 Papers
226 Citations
Peter Guarino is an academic researcher from Yale University. The author has contributed to research in topics: Randomized controlled trial & Veterans Affairs. The author has an hindex of 22, co-authored 40 publications. Previous affiliations of Peter Guarino include United States Department of Veterans Affairs & Fred Hutchinson Cancer Research Center.
Chat about Author
Papers
Robot-Assisted Therapy for Long-Term Upper-Limb Impairment after Stroke
Albert C. Lo,Peter Guarino,Lorie Richards,Jodie K. Haselkorn,George F. Wittenberg,Daniel G. Federman,Daniel G. Federman,Robert J. Ringer,Todd H. Wagner,Hermano Igo Krebs,Bruce T. Volpe,Christopher T. Bever,Dawn M. Bravata,Pamela W. Duncan,Barbara H. Corn,Alysia D. Maffucci,Stephen E. Nadeau,Susan S. Conroy,Janet M. Powell,Grant D. Huang,Peter Peduzzi +20 more
TL;DR: In patients with long-term upper-limb deficits after stroke, robot-assisted therapy did not significantly improve motor function at 12 weeks, as compared with usual care or intensive therapy.
Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
Linda F. Fried,Nicholas V. Emanuele,Nicholas V. Emanuele,Jane H. Zhang,Mary Brophy,Todd A. Conner,William C. Duckworth,William C. Duckworth,David J. Leehey,David J. Leehey,Peter A. McCullough,Theresa Z. O'Connor,Paul M. Palevsky,Robert F. Reilly,Stephen L. Seliger,Stuart R. Warren,Suzanne Watnick,Peter Peduzzi,Peter Peduzzi,Peter Guarino +19 more
TL;DR: Combination therapy with an ACE inhibitor and an ARB was associated with an increased risk of adverse events among patients with diabetic nephropathy and safety outcomes included mortality, hyperkalemia, and acute kidney injury.
Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
Walter N. Kernan,Catherine M. Viscoli,Karen L. Furie,Lawrence H. Young,Silvio E. Inzucchi,Mark Gorman,Peter Guarino,Peter Guarino,Anne M. Lovejoy,Peter Peduzzi,Peter Peduzzi,Robin Conwit,Lawrence M. Brass,Gregory G. Schwartz,Harold P. Adams,L. Berger,Antonio Carolei,Wayne M. Clark,Bruce M. Coull,Gary A. Ford,Dawn Kleindorfer,J. R. O'Leary,Mark W Parsons,Peter A. Ringleb,Souvik Sen,J. D. Spence,David Tanne,David Z. Wang,T. R. Winder +28 more
TL;DR: In this trial involving patients without diabetes who had insulin resistance along with a recent history of ischemic stroke or TIA, the risk of stroke or myocardial infarction was lower among patients who received pioglitazone than among those who received placebo.
954
Million Veteran Program: A mega-biobank to study genetic influences on health and disease.
John Michael Gaziano,John Michael Gaziano,John Concato,Mary Brophy,Mary Brophy,Louis D. Fiore,Louis D. Fiore,Saiju Pyarajan,James Breeling,Stacey B. Whitbourne,Jennifer Deen,Colleen Shannon,Donald E. Humphries,Peter Guarino,Mihaela Aslan,Daniel Anderson,Rene LaFleur,Timothy R. Hammond,Kendra L. Schaa,Jennifer Moser,Grant D. Huang,Sumitra Muralidhar,Ronald M. Przygodzki,Timothy J. O'Leary +23 more
TL;DR: The Million Veteran Program, as an observational cohort study and mega-biobank in the Department of Veterans Affairs (VA) health care system, is designed to contribute to the development of precision medicine.
952
Effect of Vitamin E and Memantine on Functional Decline in Alzheimer Disease The TEAM-AD VA Cooperative Randomized Trial
Maurice W. Dysken,Mary Sano,Sanjay Asthana,Julia E. Vertrees,Muralidhar Pallaki,Muralidhar Pallaki,Maria D. Llorente,Susan Love,Gerard D. Schellenberg,J. Riley McCarten,Julie Malphurs,Susana Prieto,Peijun Chen,Peijun Chen,David Loreck,David Loreck,George Trapp,Rajbir S. Bakshi,Jacobo Mintzer,Jacobo Mintzer,Judith L. Heidebrink,Ana Vidal-Cardona,Lillian M. Arroyo,Angel R. Cruz,Sally B. Zachariah,Neil W. Kowall,Mohit P. Chopra,Suzanne Craft,Stephen Thielke,Carolyn Turvey,Carolyn Turvey,Catherine Woodman,Catherine Woodman,Kimberly A. Monnell,Kimberly Gordon,Julie Tomaska,Yoav Segal,Peter Peduzzi,Peter Peduzzi,Peter Guarino,Peter Guarino +40 more
TL;DR: Benefit of alpha tocopherol in mild to moderate AD is suggested by slowing functional decline and decreasing caregiver burden.